Method of reducing immunoglobulin E responses
US5676940A · kind A · utility
1Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 1994 |
| Grant date | Oct 14, 1997 |
| Priority date | — |
| Expiry date | Mar 17, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of reducing immunoglobulin E responses associated with certain immune disorders is provided. The method comprises administering an effective amount of an antagonist to human interleukin-4. Preferably, the antagonist is a blocking monoclonal antibody specific for human interleukin-4, or a fragment or binding composition derived therefrom.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.